Intra-Cellular Therapies (ITCI) Tops Q2 EPS by 11c

August 5, 2015 8:53 AM EDT
Get Alerts ITCI Hot Sheet
Price: $43.18 --0%

EPS Growth %: +11.0%

Today's EPS Names:
Trade Now! 
Join SI Premium – FREE

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q2 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $57.4 million versus the consensus estimate of $40 thousand.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

The Children's Investment Fund (TCI), Earnings